Our vision is a world where cancer patients are diagnosed early and treated precisely to achieve cure.

To achieve this vision, we have formed a multidisciplinary team of molecular biologists, clinicians, technologists, and computational biologists that fosters cross-pollination of ideas. We leverage this diverse range of expertise to develop cutting edge diagnostic tools based on liquid biopsies. In the process, we train the next generation of translational scientists developing the skills and knowledge required to address pressing clinical needs in precision cancer medicine, in the US and globally.

Learn More

Affiliations